COMPASS Pathways plc (CMPS) Discusses Clinical Trial Plans for PTSD and Commercial Preparations for Treatment-Resistant Depression Transcript

Core Viewpoint - COMPASS Pathways is conducting an update webinar to provide insights into its current status and future plans [2]. Group 1 - The webinar is hosted by Stephen Schultz, Senior Vice President of Investor Relations at COMPASS Pathways [2]. - The call is being recorded and will be available on the COMPASS Pathways Investor Relations website for 30 days after the conclusion of the call [2]. Group 2 - Participants are reminded that the team will make forward-looking statements regarding future plans and prospects during the call [3].